Citi Starts Mirum Pharmaceuticals (MIRM) at Buy
Citi analyst Yigal Nochomovitz initiates coverage on Mirum Pharmaceuticals (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
